We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
-5.52%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$19.8B
AUM Growth
-$3.84B
Cap. Flow
-$2.53B
Cap. Flow %
-12.83%
Top 10 Hldgs %
32.02%
Holding
1,045
New
60
Increased
301
Reduced
498
Closed
179

Sector Composition

Rank Sector Weight
1 Consumer Staples 29.71%
2 Healthcare 20.65%
3 Consumer Discretionary 10.85%
4 Financials 7.63%
5 Technology 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRI icon
851
Enviri
NVRI
$620M
$213K ﹤0.01%
57,054
-1,968
-3% -$10.9K
NWL icon
852
Newell Brands
NWL
$2.56B
$208K ﹤0.01%
14,976
-85,609
-85% -$1.6M
BNR
853
Burning Rock Biotech
BNR
$92.9M
$207K ﹤0.01%
8,672
-297
-3% -$9.59K
LSXMA
854
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$202K ﹤0.01%
+7,211
New +$213K
FRSH icon
855
Freshworks
FRSH
$3.27B
$180K ﹤0.01%
+13,850
New +$196K
HST icon
856
Host Hotels & Resorts
HST
$16B
$176K ﹤0.01%
+11,110
New +$194K
GOTU icon
857
Gaotu Techedu
GOTU
$436M
$162K ﹤0.01%
134,127
-4,721
-3% -$7.63K
QS icon
858
QuantumScape Corp
QS
$3.74B
$151K ﹤0.01%
17,948
-14,809
-45% -$159K
AMC icon
859
AMC Entertainment Holdings
AMC
$2.31B
$150K ﹤0.01%
+2,158
New +$295K
ADT icon
860
ADT
ADT
$5.58B
$114K ﹤0.01%
15,223
+2,558
+20% +$19.3K
CDXS icon
861
Codexis
CDXS
$158M
$114K ﹤0.01%
18,736
-878
-4% -$7.06K
DOYU
862
DouYu International Holdings
DOYU
$142M
$113K ﹤0.01%
11,320
-173
-2% -$2.19K
CLVT icon
863
Clarivate
CLVT
$1.16B
$106K ﹤0.01%
+11,251
New +$142K
ANGI icon
864
Angi Inc
ANGI
$196M
$62K ﹤0.01%
2,105
-1,349
-39% -$59.4K
AUR icon
865
Aurora
AUR
$13.8B
$43K ﹤0.01%
19,436
-64,171
-77% -$159K
OPK icon
866
Opko Health
OPK
$1.02B
$25K ﹤0.01%
+13,209
New +$31.2K
AAP icon
867
Advance Auto Parts
AAP
$3.49B
-40,548
Closed -$7.02M
ACAD icon
868
Acadia Pharmaceuticals
ACAD
$5.03B
-10,918
Closed -$154K
ADNT icon
869
Adient
ADNT
$1.5B
-66,124
Closed -$1.96M
ADSK icon
870
Autodesk
ADSK
$52.6B
-7,777
Closed -$1.34M
AEO icon
871
American Eagle Outfitters
AEO
$3.01B
-30,248
Closed -$338K
ALLE icon
872
Allegion
ALLE
$14.4B
-60,354
Closed -$5.91M
AMZN icon
873
Amazon
AMZN
$2.96T
-149,250
Closed -$15.9M
ANSS
874
DELISTED
Ansys
ANSS
-6,786
Closed -$1.62M
AOS icon
875
A.O. Smith
AOS
$8.7B
-114,558
Closed -$6.26M

Similar funds

Ray Dalio's Q3 2022 Portfolio in Review

As of Q3 2022, Ray Dalio held 1,045 positions worth $19.8B, down 16% from $23.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ray Dalio withdrew a net $2.53B in Q3 2022, closing 179 positions and reducing 498 holdings. Its most notable exit was Medtronic, an estimated $225M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ray Dalio opened a new position in Accenture worth $29.3M.

  • Ray Dalio's largest Q3 2022 buy was Accenture: 113,811 shares worth $29.3M.
  • Ray Dalio added most to Visa in Q3 2022, an estimated $148M increase.
  • Ray Dalio's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $151M.
  • Ray Dalio fully exited Medtronic in Q3 2022, selling an estimated $225M.
  • Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q3 2022.
  • Ray Dalio opened 60 new positions and closed 179 in Q3 2022.
  • Ray Dalio's portfolio value fell 16% quarter-over-quarter to $19.8B.

Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.